Background Image
Table of Contents Table of Contents
Previous Page  11 / 18 Next Page
Information
Show Menu
Previous Page 11 / 18 Next Page
Page Background

SA JOURNAL OF DIABETES & VASCULAR DISEASE

RESEARCH ARTICLE

VOLUME 18 NUMBER 1 • JULY 2021

9

9. Seyoum B, Kiros K, Haileselase T, Leole A. Prevalence of gestational diabetes

mellitus in rural pregnant mothers in northern Ethiopia.

Diabetes Res Clin Prac

1999;

46

: 247–251.

10. Ozumba BC, Obi SN, Oli JM. Diabetes mellitus in pregnancy in an African

population.

Int J Gynecol Obstet

2004;

84

(2): 114–119.

11. Mamabolo RL, Alberts M, Levitt NS, Delemarre-van de Waal HA, Steyn NP.

Prevalence of gestational diabetes mellitus and the effect of weight on

measures of insulin secretion and insulin resistance in third-trimester pregnant

rural women residing in the Central Region of Limpopo Province, South Africa.

Diabet Med

2007;

24

; 233–239.

12. Kuti MA, Abbiyesuku FM, Akinlade KS, Akinosun OM, Adedapo KS, Adeleye

JO,

et al

. Oral glucose tolerance testing outcomes among women at high risk

for gestational diabetes mellitus.

J Clin Pathol

2011;

64

(8): 718–721.

13. Msyamboza KP, Mvula C, Kathyola D. Prevalence and correlates of diabetes

mellitus in Malawi: population-based national NCD STEPS survey.

BMC

Endocrine Disord

2014;

14

: 41.

14. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS; Australian

Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect

of treatment of gestational diabetes mellitus on pregnancy outcomes.

N Engl J

Med

2005;

352

: 2477–2486.

15. HAPO Study Cooperative Research Group. Hyperglycemia and adverse

pregnancy outcomes.

N Engl J Med

2008;

358

: 1991–2002.

16. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P,

et al

. International association of diabetes and pregnancy study groups

recommendations on the diagnosis and classification of hyperglycemia in

pregnancy.

Diabetes Care

2010;

33

: 676–682.

17. Cundy T, Ackermann E, Ryan EA. Gestational diabetes: new criteria may triple

the prevalence but effect on outcomes is unclear.

Br Med J

2014;

348

: 1567.

18. Reece EA, Thomas M. The diagnostic criteria for gestational diabetes: to change

or not to change?

Am J Obstet Gynecol

2013;

208

(4): 255–259.

19. Wendland EM, Torloni MR, Falavigna M, Trujillo J, Dode MA, Campos MA,

et al

. Gestational diabetes and pregnancy outcomes – a systematic review

of the World Health Organization (WHO) and the International Association

of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria.

BMC

Pregnancy Childbirth

2012;

12

: 23.

20. Tieu J, Middleton P, McPhee AJ, Crowther CA. Screening and subsequent

management for gestational diabetes for improving maternal and infant health.

Cochrane Database Syst Rev

2010;

7

: CD007222.

21. Malawi National Statistical Office 2008 Population and Housing Census Results.

Available:

http://www.nsomalawi.mw/index.php/2008-population-and-housing-

census/107-2008-population-and-housing-census-results.html.

22. World Health Organization. Diagnostic criteria and classification of hyperglycaemia

first detected in pregnancy. 2013.

23. Tang AM, Dong K, Deitchler M, Chung M, Maalouf-Manasseh Z, Tumilowicz A,

et al

. Use of cut-offs for mid-upper arm circumference (MUAC) as an indicator or

predictor of nutritional and health-related outcomes in adolescents and adults: a

systematic review. Washington, DC: FHI 360/FANTA, 2013

PEARINDA 4, 8.

Each tablet contains 4, 8 mg perindopril

tert

-butylamine respectively. S3 A41/7.1.3/0649,

0650. NAM NS2 10/7.1.3/0476, 0477.

PEARINDA PLUS 4.

Each tablet contains 4 mg perindopril

tert

-

butylamine and 1,25 mg indapamide. S3 A41/7.1.3/0633. NAM NS2 10/7.1.3/0611. For full prescribing

information, refer to the professional information approved by SAHPRA, 2 January 2020.

1)

Oparil S. Efficacy

of perindopril in the treatment of systemic hypertension.

The American Journal of Cardiology

2001;88(7A):

3i-12i.

2)

Ancion A,

et al.

A review of the role of bradykinin and nitric oxide in the cardioprotective action of

angiotensin-converting enzyme inhibitors: Focus on perindopril.

Cardiology and Therapy

2019;8:179-191.

PAI743/05/2021.

CUSTOMER CARE LINE

0860 PHARMA (742 762)

www.pharmadynamics.co.za

Need

endurance

when treating CVS disease?

PERINDOPRIL

• Maintains its antihypertensive

ecacy despite missed doses

1

• Improves endothelial dysfunction

2

• Has proven outcomes in a broad

range of patients

2

the

endurance

ACE-inhibitor

24. Okereke CE, Anyaehie UB, Dim CC, Iyare EE, Nwagha UI. Evaluation of some

anthropometric indices for the diagnosis of obesity in pregnancy in Nigeria: a

cross-sectional study.

Afr Health Sci

2013;

13

(4): 1034–1040.

25. Cohen DB, Allain TJ , Glover S, Chimbayo D, Dzamalala H, Hofland HW,

et al

.

A Survey of the management, control, and complications of diabetes mellitus

in patients attending a diabetes clinic in Blantyre, Malawi, an area of high HIV

prevalence.

Am J Trop Med Hyg

2010;

83

(3): 575–581.

26. Leary J, Pettitt DJ, Jovanovic L. Gestational diabetes guidelines in a HAPO world.

Best Pract Res Clin Endocrinol Metab

2010;

24

(4): 673.